QMED — QMed Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for QMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	R2003 November 30th	R2004 November 30th	R2005 November 30th	R2006 November 30th	2007 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12.7	15.3	22	8.14	5.25
Cost of Revenue
Gross Profit	6.12	6.72	14.6	3.37	2.51
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	14.5	16.8	16.2	18.7	12.6
Operating Profit	-1.88	-1.45	5.72	-10.6	-7.39
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2.17	-1.9	5.29	-9.53	-4.82
Provision for Income Taxes
Net Income After Taxes	-2.19	-1.69	5.01	-9.49	-4.85
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-2.15	-1.74	3.89	-14.2	-11.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-2.15	-1.74	3.89	-14.2	-11.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.14	-0.114	0.271	-0.565	-0.286
Dividends per Share